Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $0.45 Analyst target: $3.33 Upside: 640.67%
InspireMD, Inc., a medical device company, is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of coronary and vascular disease in Europe, Latin America, the Middle East, and Asia. The company is headquartered in Tel Aviv, Israel.
See the full interactive analysis & chart →Informational only — not investment advice.